Cannabidiol Regulates Gene Expression in Encephalitogenic T cells Using Histone Methylation and noncoding RNA during Experimental Autoimmune Encephalomyelitis
Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina Columbia, South Carolina, 29209 USA
Abstract
Cannabidiol (CBD) has been shown by our laboratory to attenuate experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). In this study, we used microarray and next generation sequencing (NGS)-based approaches to determine whether CBD would alter genome-wide histone modification and gene expression in MOG sensitized lymphocytes. We compared H3K4me3 and H3K27me3 marks in CD4+ T cells from naïve, EAE and CBD treated EAE mice by ChIP-seq. Although the overall methylation level of these two histone marks did not change significantly, the signal intensity and coverage differed in individual genes, suggesting that CBD may modulate gene expression by altering histone methylation. Further analysis showed that these histone methylation signals were differentially enriched in the binding sites of certain transcription factors, such as ZNF143 and FoxA1, suggesting that these transcription factors may play important roles in CBD mediated immune modulation. Using microarray analysis, we found that the expression pattern of many EAE-induced genes was reversed by CBD treatment which was consistent with its effect on attenuating the clinical symptoms of EAE. A unique finding of this study was that the expression of many miRNAs and lncRNAs was dramatically affected by CBD. In summary, this study demonstrates that CBD suppresses inflammation through multiple mechanisms, from histone methylation to miRNA to lncRNA.
Untitled section
Subject terms: Long non-coding RNAs, Epigenetics in immune cells
Article notes
Untitled section
Received 2019 May 31; Accepted 2019 Sep 30; Collection date 2019.
Introduction
Marijuana (Cannabis sativa) has many biologically active compounds and its medicinal value has been known for centuries. Two main active ingredients in marijuana are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC, the psychotropic component, is used for pain relief, stimulating appetite, and as an anti-emetic in cancer and HIV/AIDS patients1. CBD is a non-psychoactive compound in marijuana with potential efficacy against epilepsy and autoimmune diseases2. THC exerts its function through cannabinoid receptors, CB1 and CB2. CB1 is predominantly expressed in the brain while CB2 is primarily found on immune cells3. However, CBD does not bind to or activate cannabinoid receptors directly. In neuronal cells, CBD demonstrates agonist activity on 5-HT1A receptor and regulates 5-HT1A receptor-mediated neurotransmission4,5. In immune system, studies from our lab as well as those from others have shown that both THC and CBD have anti-inflammatory properties2,6–9. CBD has been shown to attenuate many autoimmune diseases including experimental autoimmune encephalomyelitis (EAE), autoimmune hepatitis, colitis and collagen-induced arthritis6,8,10,11. CBD may exert some of its effect through several receptors, including vanilloid receptor 1 (TRPV1), G-coupled receptor 55 (GPR55), and 5-HT1A receptors depending on the disease model.
EAE is an animal model of multiple sclerosis (MS). MS is a neurodegenerative autoimmune disease. The disease often begins with inflammatory attacks against the white matter of the brain, producing neurological disorders including loss of sensation, lack of coordination, bowel and bladder incontinence, difficulty in walking and paralysis12. EAE partially mimics the immunopathological process of MS by immunizing mice with myelin-derived antigens such as myelin basic protein (MBP), proteolipid protein (PLP), myelin associated glycoprotein (MAG) and myelin oligodendrocyte glycoprotein (MOG)13. These immunodominant antigenic epitopes trigger acute and chronic autoimmune disease. It has been shown that in EAE models and MS patients, naïve CD4+ T cells can differentiate into pro-inflammatory Th1 and Th17 cells which cross blood-brain barrier and contribute to neuro inflammation14–16. On the other hand, FoxP3 + regulatory T cells (Tregs) play a critical role in the downregulation of EAE17. In addition, previous studies from our lab have demonstrated that CBD can also attenuate clinical symptoms of EAE by inducing immunosuppressive Myeloid-derived Suppressor Cells (MDSC)6.
Although THC and CBD have shown anti-inflammatory property in various disease models, the underlying mechanism is not clear. Our studies have suggested the THC and CBD may modulate histone modification and miRNA expression in immune cells. For example, THC regulates gene expression in lymphocytes by altering histone methylation and acetylation18,19. In this study, we investigated whether activation of T cells with MOG antigen would alter gene expression and histone methylation leading to differentiation of T cells into proinflammatory phenotype and whether CBD treatment would reverse these effects. To that end, we used microarray and next generation sequencing (NGS)-based approaches to determine whether CBD could alter histone methylation (H3K4me3 and H3K27me3), and expression of non-coding RNA (miRNA and long non coding RNA (lncRNA)) in CD4+ T lymphocytes from naïve, MOG + vehicle and MOG + CBD treated mice. Our results suggested that histone methylation as well as non coding RNAs may play important roles in inflammatory T cell development and that CBD-mediated immune modulation may result from restoration of such alterations.
Results
Effect of CBD on genome-wide histone H3K4me3 and H3K27me3 methylation in splenic CD4+ T cells
MOG-induced EAE is a well-established mouse model of MS. Recently, we demonstrated that CBD was highly effective in attenuating EAE6. To determine whether CBD would affect histone modification in CBD-mediated regulation of T cell functions in this model, we examined two histone marks, H3K4me3 and H3K27me3. While many types of histone methylation have been shown to regulate gene expression, these two histone marks are the most well studied ones. H3K4me3 in the promoter region is associated with transcription activation and H3K27me3 is associated with transcription repression. The global histone methylation profile was examined by ChIP-seq in splenic CD4+ T cells from naïve, MOG + vehicle and MOG + CBD treated mice. The overall genome-wide H3K4me3 and H3K27me3 levels did not differ significantly among those 3 groups (Fig. 1a). However, the intensity and/or coverage of these histone marks in certain genomic regions was significantly altered by CBD in EAE mice. For example, the histone marks differed significantly in the genes of Th2 related cytokines such as IL-4, IL-5 and IL13 (Fig. 1b). Both marks showed lower levels of coverage in naïve cells when compared to MOG-activated cells, suggesting that histone methylation might be important for the expression of these cytokines in MOG activated T cells. Compared to vehicle treatment, CBD treatment led to a lower coverage of H3K27me3 but a higher level coverage of H3K4me3 in these genes, suggesting that CBD might cause an increase in the expression of these anti-inflammatory cytokines. The expression of IL-4, IL-5 and IL-13 in those 3 groups was further determined by real time PCR (Fig. 1c). When T cells were activated by MOG, the expression of IL-5 and IL-13 was significantly increased. CBD treatment tended to further increase their expressions although the difference was only significant for IL-4. This result indicated that besides H3K4me3 and H3K27me3, other histone/DNA modifications could also play important roles in the expression of these cytokines in EAE.
Because many transcription factors are involved in immune regulation, we further determined whether these 2 histone marks were differentially enriched in certain transcription factor binding motifs. By performing signal enrichment assay, we identified top 10 transcription factor binding motifs with enriched H3K4me3 or H3K27me3 signal after T cell activation by MOG (Fig. 2a,c). We also identified signal enriched motifs in CBD treated vs. vehicle treated cells (Fig. 2b,d). Among them were binding motifs of ZNF143, c-Myc, RUN family and FoxA1. ZNF143 and RUN family members are known to regulate DNA replication and cell cycle20,21, while FoxA1 is the factor for the development of a subset of Treg population22. Since histone modification affects transcription factor accessibility, the results suggest that genes whose expression is regulated by these transcription factors may be important for MOG-induced inflammation as well as CBD-induced anti-inflammation.
CBD-mediated alteration in miRNA expression
Inasmuch as miRNAs are known to play important role in the regulation of immune response, we compared the expression of mature miRNAs in splenic CD4+ T cells from naïve, MOG + vehicle and MOG + CBD groups by microarray. Among 1910 total mature miRNAs, 232 were significantly induced in MOG-activated T cells when compared to naïve T cells. Within those 232 miRNAs, 74 of them were suppressed after CBD treatment. On the other hand, MOG-treatment led to decreased expression of 118 miRNAs compared to naïve and only 23 of them whose expression was reversed by CBD treatment (see Supplementary Data). Figure 3 is the heat map of miRNA expression in these 3 groups.
CBD-mediated alteration in transcriptome expression
We also used microarray to compare the transcriptome expression profile in CD4+ T cells isolated from these 3 groups of mice. MOG stimulation changed the expression of many transcripts. Among those altered transcripts, the expression pattern of 1272 transcripts was reversed by CBD treatment. CBD suppressed 876 MOG-induced transcripts, and induced 396 MOG-suppressed transcripts. Interestingly, majority of those altered transcripts were non-coding transcripts. CBD reversed the expression of 556 MOG altered protein coding transcripts and 716 non-coding transcripts (Fig. 4) (see Supplementary Data). Pathway analysis revealed that most altered protein coding transcripts were involved in cell cycle and immune response, which is consistent with the results that MOG increases while CBD inhibits T cell proliferation. The immune related genes as well as their cellular locations are presented in Fig. 5. We also paired altered miRNA from miRNA array with their potential targets from transcriptome array through the use of IPA (QIAGEN Inc., https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis)23. Because miRNA usually suppress the expression of their targets, we only paired the protein coding genes and miRNAs that had opposite expression patterns after CBD treatment (Fig. 6).
CBD mediated change in long non-coding RNA expression
Transcriptome array results showed that CBD altered the expression of many lncRNAs in splenic T cells in MOG-induced EAE mice. However, most of these lncRNAs are predicted ones and have not been validated experimentally. We selected some validated lncRNAs (AW112010 (AW), Mirt2, Neat1, 170071M16Rik (M16), 201011I01Rik (I01), 4931406H21Rik (H21), 6330407A03Rik (A03) and 9310230L23Rik (L23)), and their expressions in CD4+ T cells after MOG + vehicle and MOG + CBD treatment, were further confirmed by real time PCR (Fig. 7a). Although the functions of those lncRNAs are not known at the present time, the results indicated that those lncRNAs might play an important role in MOG-induced EAE development as well as CBD-mediated immune modulation. To determine whether their expressions correlated with histone/DNA modifications, we examined H3K4me3, H3K27me3 and 5mC in their genomic regions. The result suggested that the activation mark H3K4me3 was important for the expression of lncRNA A03, H21, M16 and Mirt2 (Fig. 7b). The suppressive marks might play an important role in the expression of Neat1, because in naïve T cells which had a low expression level, showed increased signals of H3K27me3 in its promoter and 5mC in its promoter CpG island (Fig. 7c). Overall, the patterns of histone H3K4me3 and H3K27me3 methylation as well as 5mC were consistent with the expression patterns of these lncRNAs.
Discussion
CBD has been shown to have an anti-inflammatory effect in several animal models. While our previous studies demonstrated that CBD can induce MDSCs that are highly immunosuppressive and which upon adoptive transfer can attenuate EAE, the direct effect of CBD on T cells was not investigated. In this study, we examined the effects of CBD on global histone H3K4me3 and H3K27me3 methylation and gene expression in splenic CD4+ T cells from EAE mice. Despite the fact that MOG treatment dramatically increases transcription activity in T cells, the overall histone methylation levels do not differ significantly when compared to those in T cells from naïve mice. These results are similar to those from our previous study regarding the effect of THC on histone methylation in SEB activated lymphocytes19. These results indicate that MOG stimulation and CBD treatment may not alter global histone methylation/de-methylation activity. However, signal enrichment assay indicates that serval transcription binding motifs are differentially associated with histone methylation marks after CBD treatment in EAE mice. Among them is ZNF143 binding motifs. ZNF143 is a zinc finger protein which is critical for chromatin interaction at promoter area to regulate gene expression24. ZNF143 binds to promoters and is required for cell type specific chromatin interactions connecting promoters and regulatory elements24. Histone methylation such as H3K4me1 and H3K27ac in the ZNF143 binding sites has been linked to transcription activation24. In this study, we have found that ZNF143 binding motif is the top enriched motif associated H3K4me3 mark after MOG treatment, which suggests an enhanced activity of ZNF143 mediated transcription. Interestingly, ZNF143 binding motif is also the top enriched motif associated with the suppressive mark, H3K27me3, after CBD treatment in MOG stimulated cells, suggesting that both active and suppressive histone marks can modulate ZNF143 binding, which in turn, regulate gene expression.
FoxA1 binding motif is the top enriched motif with H3K4me3 mark after CBD treatment compared to the vehicle treatment in MOG stimulated cells. FoxA1 is a member of fork head family transcription factors and regulates the lineage-specific transcription25. It has been shown that FoxA1 binds to distinct regions within the genome with specific epigenetic modifications. FoxA1 binding sites have significant enrichment for transcription active marks, H3K4me1 and me225. Our results suggest that CBD can also lead to the enrichment of H3K4me3 in the FoxA1 binding motif. Although FoxP3-expressing Treg cells have been shown to control inflammation in EAE model, studies have also suggested that other immunosuppressive T cells, such as FoxA1+ Treg cells, are involved in EAE and MS22,26–28. FoxA1+ Treg cells have been identified as IFN-β induced, linage-specific immunosuppressive cells, and IFN-β deletion leads to augmented symptoms of EAE29.
In our previous studies, we used RNA-seq to examine effect of cannabinoids such as THC on pri/pre-miRNA expression in SEB challenged lymphocytes18. Because the expression profile of precursor miRNAs may not correlate with their mature forms, we used microarray to determine mature miRNA expression in this study. Among those identified miRNA, some are known to regulate immune response. For example, miR-155 has been shown by us as well as by others to have pro-inflammatory property30. Some miRNAs such as miR-19, -210 and -223 that are up- regulated in T cells in MOG-induced EAE mice are also up-regulated in T cells from patients with MS31. On the other hand, few miRNAs such as miR-181c are down-regulated in EAE compared to naïve. miR-181c is also down-regulated in MS patients31. Furthermore, decreased expression of miR-181c in peripheral blood mononuclear cells from patients with myasthenia gravis correlates with elevated serum IL-7 and IL-1732. Knockdown of miR-181 has also been shown to enhance LPS-induced production of pro-inflammatory cytokines33, suggesting that miR-181c has an anti-inflammatory property. More importantly, the expression patterns of these miRNAs in EAE are reversed by CBD, indicating that modulating the expression of miRNA may constitute one of the mechanisms by which CBD exerts its anti-inflammatory roles in EAE and MS.
Long non coding RNA is another layer of gene expression regulation. We have found that many lncRNAs are induced by MOG treatment. However, the only lncRNA with known function is Neat1 (Nuclear-Enriched Autosomal Transcript 1). Neat1 is essential for the formation of paraspeckes in the nucleus and is a potent regulator in cell proliferation and differentiation34,35. Several studies have shown that aberrant expression of Neat1 is associated with various types of cancer, and its overexpression correlates with poor prognosis36,37. Overall, Neat1 seems to promote cell proliferation which is consistent with our results that MOG significantly induces Neat1 expression in T cells. Neat1 has also been shown to have a pro-inflammatory property. Neat1 expression is increased in Systemic Lupus Erythematosus and knockdown of Neat1 reduces cytokines such as IL-6 and CXCL1038. The expression of Neat1 is also induced by certain viral infections and facilitates the expression of antiviral cytokines such as IL-839. Another MOG-induced lncRNA which is suppressed by CBD is Mirt2 (myocardial infarction-associated transcript 2). It is one of 2 lncRNAs that is up regulated in mice with myocardial infarction40. Further study has shown that Mirt2 may be involved in left ventricular remodeling40. A recent study shows that the expression of Mirt2 in macrophages is induced by LPS41. Furthermore, Mirt2 inhibits the activation of NF-kB and MAPK pathways to limit the expression of proinflammatory cytokines and thus it may serve as a negative regulator of inflammation41. Another lncRNA, AW112010, was initially identified as a transcript that might encode a small peptide but was classified as a non-coding RNA42. The role of this lncRNA is not known. One study shows that AW112010 is induced in microglia and astrocyte in CNS after virus infection, suggesting it may be involved in inflammation43.
In summary, the current study demonstrates that CBD modulates immune response through various mechanisms, from histone and DNA methylation to miRNA and lncRNA expression. The main purpose of this study is to identify potential regulatory elements in CBD-mediated immune modulation. Many candidates identified in this study have no known function and thus the current study provides new avenues to investigate their roles in regulating inflammation.
Materials and Methods
Induction of EAE and Cell Isolation
EAE was induced in female C57BL/6 J mice (8–10 weeks old) by subcutaneous injection of MOG35–55 (NeoMPS, San Diego, CA), as described6,44,45. Each mouse received 150 μg of MOG in 100 μl of complete Freund’s adjuvant with 100 μg of inactivated Mycobacterium tuberculosis. Mice also received 200 ng of pertussis toxin (Sigma) in 100 μl of PBS by intraperitoneal injection. Pertussis toxin was injected again 2 days after MOG injection. After MOG injection, mice received CBD (10 mg/kg of body weight) or the vehicle daily by intraperitoneal injection. All animal experiments were carried out in accordance with NIH guideline and approved by University of South Carolina IACUC (protocol #2363; approval data: May 31, 2017). After 7 days, spleens from the naïve control, MOG + vehicle and MOG + CBD (4–7 mice in each group) were collected and single cell suspension was prepared. CD4+ T cells were isolated using EasySep selection kit (StemCell Technologies, Vancouver, BC) according to the provided instructions. The antibody used was FITC-anti-mouse CD4 (BioLegend, San Diego, CA). Isolated cells were cultured in complete RPMI1640 medium. For the MOG + vehicle group, 30 μg/ml of MOG was added to the medium. For the MOG + CBD group, 30 μg/ml of MOG and 10 μM of CBD were added to the medium. Cells were harvested after 48 hr of culturing.
ChIP-seq
ChIP-seq was performed as described previously19,46. Briefly, crosslinked chromatin was fragmented by Micrococcal nuclease digestion and immunoprecipitated with anti-H3K4me3 or anti-H3K27me3 antibodies (Abcam, Cambridge, MA). After ChIP, the crosslinking was reversed and DNA fragments were purified. The sequencing library was constructed using Illumina’s TruSeq sample preparation kit according to the provided instruction. The samples before immunoprecipitation served as input controls. Sequencing was performed using Illumina Nextseq 500 sequencer.
miRNA and transcriptome microarray
RNA was purified by RNeasy and miRNeasy kit (Qiagen,). For miRNA quantification by Affymetrix GeneChip miRNA array, mature miRNAs were labeled by FlashTag Biotin HSR RNA labeling kit. For transcriptome expression analysis by GeneChip Whole Transcript Expression Array, samples were amplified and labeled using GeneChip WT PLUS reagent kit. Microarray hybridization, wash and staining were performed using the Fluidics Station 450. All procedures were carried out according to the protocols provided by Affymetrix. Data were analyzed by Affymetrix Expression Console software. Fold changes >1.5 were considered as significant.
Quantitative Real-time PCR
Total RNA including miRNA was reverse transcribed by miScript II RT kit (Qiagen). mRNA expression was measured by SYBR Green PCR kit and mature miRNA was quantified by miScript Primer Assays (Qiagen). Snord96a and Gapdh were used as the internal controls for miRNA and mRNA, respectively. The amount in the naïve CD4+ T cells was set as 1.
Data analysis
ChIP-seq data were analyzed as described previously19,46. The signals were visualized in Integrated Genome Browser (www.bioviz.org) using mouse mm9 genome build as the reference. The genome-wide histone methylation map was generated by the Circos plot47. The signal enriched motifs were identified using HOMER motif analysis software48. The heatmaps were generated by the R program. Ingenuity Pathway Analysis (Qiagen) was used for functional analysis and pairing of miRNA and mRNA. Statistical analysis was performed using T test (For animal experiments, each group had 4 to 7 mice. For qPCR, n = 3). Significance was determined as p < 0.05 (denoted by *).
Supplementary information
Untitled section
Acknowledgements
This study was supported by NIH grants R01ES019313, R01MH094755, R01AI123947, R01 AI129788, P01 AT003961, P20 GM103641, R01 AT006888 awarded to MN and PSN.
Competing interests
The authors declare no competing interests.
Footnotes
Footnote Group
Supplementary information
is available for this paper at 10.1038/s41598-019-52362-8.
References
Untitled section
References
- 1.Whiting PF, et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015;313:2456–2473. doi: 10.1001/jama.2015.6358.
- 2.Burstein S. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorganic & medicinal chemistry. 2015;23:1377–1385. doi: 10.1016/j.bmc.2015.01.059.
- 3.Felder CC, Glass M. Cannabinoid receptors and their endogenous agonists. Annu Rev Pharmacol Toxicol. 1998;38:179–200. doi: 10.1146/annurev.pharmtox.38.1.179.
- 4.Fogaca MV, Reis FM, Campos AC, Guimaraes FS. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. 2014;24:410–419. doi: 10.1016/j.euroneuro.2013.10.012.
- 5.Russo EB, Burnett A, Hall B, Parker KK. Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochemical research. 2005;30:1037–1043. doi: 10.1007/s11064-005-6978-1.
- 6.Elliott DM, Singh N, Nagarkatti M, Nagarkatti PS. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells. Frontiers in immunology. 2018;9:1782. doi: 10.3389/fimmu.2018.01782.
- 7.Hegde VL, et al. Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. Mol Pharmacol. 2008;74:20–33. doi: 10.1124/mol.108.047035.
- 8.Hegde VL, Nagarkatti PS, Nagarkatti M. Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol. PLoS One. 2011;6:e18281. doi: 10.1371/journal.pone.0018281.
- 9.Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 2009;1:1333–1349. doi: 10.4155/fmc.09.93.
- 10.Malfait AM, et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci USA. 2000;97:9561–9566. doi: 10.1073/pnas.160105897.
- 11.Schicho R, Storr M. Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice. Pharmacology. 2012;89:149–155. doi: 10.1159/000336871.
- 12.Siffrin V, Vogt J, Radbruch H, Nitsch R, Zipp F. Multiple sclerosis - candidate mechanisms underlying CNS atrophy. Trends in neurosciences. 2010;33:202–210. doi: 10.1016/j.tins.2010.01.002.
- 13.Constantinescu CS, Farooqi N, O’Brien K, Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS) Br J Pharmacol. 2011;164:1079–1106. doi: 10.1111/j.1476-5381.2011.01302.x.
- 14.Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol. 2010;162:1–11. doi: 10.1111/j.1365-2249.2010.04143.x.
- 15.Domingues HS, Mues M, Lassmann H, Wekerle H, Krishnamoorthy G. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS One. 2010;5:e15531. doi: 10.1371/journal.pone.0015531.
- 16.Jager A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol. 2009;183:7169–7177. doi: 10.4049/jimmunol.0901906.
- 17.O’Connor RA, Anderton SM. Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease. J Neuroimmunol. 2008;193:1–11. doi: 10.1016/j.jneuroim.2007.11.016.
- 18.Yang X, Bam M, Nagarkatti PS, Nagarkatti M. RNA-seq Analysis of delta9-Tetrahydrocannabinol-treated T Cells Reveals Altered Gene Expression Profiles That Regulate Immune Response and Cell Proliferation. J Biol Chem. 2016;291:15460–15472. doi: 10.1074/jbc.M116.719179.
- 19.Yang X, et al. Histone modifications are associated with Delta9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses. J Biol Chem. 2014;289:18707–18718. doi: 10.1074/jbc.M113.545210.
- 20.Izumi H, et al. Role of ZNF143 in tumor growth through transcriptional regulation of DNA replication and cell-cycle-associated genes. Cancer science. 2010;101:2538–2545. doi: 10.1111/j.1349-7006.2010.01725.x.
- 21.Chuang LS, Krishnan V, Ito Y. Aurora kinase and RUNX: Reaching beyond transcription. Cell Cycle. 2016;15:2999–3000. doi: 10.1080/15384101.2016.1214031.
- 22.Liu Y, et al. FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS. Nature medicine. 2014;20:272–282. doi: 10.1038/nm.3485.
- 23.Kramer A, Green J, Pollard J, Jr., Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30:523–530. doi: 10.1093/bioinformatics/btt703.
- 24.Bailey SD, et al. ZNF143 provides sequence specificity to secure chromatin interactions at gene promoters. Nature communications. 2015;2:6186. doi: 10.1038/ncomms7186.
- 25.Lupien M, et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell. 2008;132:958–970. doi: 10.1016/j.cell.2008.01.018.
- 26.Liu Y, Teige I, Birnir B, Issazadeh-Navikas S. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nature medicine. 2006;12:518–525. doi: 10.1038/nm1402.
- 27.Korn T, et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nature medicine. 2007;13:423–431. doi: 10.1038/nm1564.
- 28.Liu Y, et al. Inhibition of p300 impairs Foxp3(+) T regulatory cell function and promotes antitumor immunity. Nature medicine. 2013;19:1173–1177. doi: 10.1038/nm.3286.
- 29.Teige I, et al. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J Immunol. 2003;170:4776–4784. doi: 10.4049/jimmunol.170.9.4776.
- 30.O’Connell RM, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity. 2010;33:607–619. doi: 10.1016/j.immuni.2010.09.009.
- 31.Ma X, et al. Expression, regulation and function of microRNAs in multiple sclerosis. Int J Med Sci. 2014;11:810–818. doi: 10.7150/ijms.8647.
- 32.Zhang Y, et al. Decreased microRNA miR-181c expression in peripheral blood mononuclear cells correlates with elevated serum levels of IL-7 and IL-17 in patients with myasthenia gravis. Clinical and experimental medicine. 2016;16:413–421. doi: 10.1007/s10238-015-0358-1.
- 33.Hutchison ER, et al. Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes. Glia. 2013;61:1018–1028. doi: 10.1002/glia.22483.
- 34.Bond CS, Fox AH. Paraspeckles: nuclear bodies built on long noncoding RNA. J Cell Biol. 2009;186:637–644. doi: 10.1083/jcb.200906113.
- 35.Barry G, et al. The long non-coding RNA NEAT1 is responsive to neuronal activity and is associated with hyperexcitability states. Sci Rep. 2017;7:40127. doi: 10.1038/srep40127.
- 36.Adriaens C. & Marine, J. C. NEAT1-containing paraspeckles: Central hubs in stress response and tumor formation. Cell Cycle. 2017;16:137–138. doi: 10.1080/15384101.2016.1235847.
- 37.Yang C, et al. Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis. Oncotarget. 2017;8:2672–2680. doi: 10.18632/oncotarget.13737.
- 38.Zhang F, et al. Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus. Journal of autoimmunity. 2016;75:96–104. doi: 10.1016/j.jaut.2016.07.012.
- 39.Imamura K, et al. Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli. Mol Cell. 2014;53:393–406. doi: 10.1016/j.molcel.2014.01.009.
- 40.Zangrando J, et al. Identification of candidate long non-coding RNAs in response to myocardial infarction. BMC Genomics. 2014;15:460. doi: 10.1186/1471-2164-15-460.
- 41.Du M, et al. The LPS-inducible lncRNA Mirt2 is a negative regulator of inflammation. Nature communications. 2017;8:2049. doi: 10.1038/s41467-017-02229-1.
- 42.Skarnes WC, et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature. 2011;474:337–342. doi: 10.1038/nature10163.
- 43.Madeddu S, et al. Identification of Glial Activation Markers by Comparison of Transcriptome Changes between Astrocytes and Microglia following Innate Immune Stimulation. PLoS One. 2015;10:e0127336. doi: 10.1371/journal.pone.0127336.
- 44.Guan H, Nagarkatti PS, Nagarkatti M. CD44 Reciprocally regulates the differentiation of encephalitogenic Th1/Th17 and Th2/regulatory T cells through epigenetic modulation involving DNA methylation of cytokine gene promoters, thereby controlling the development of experimental autoimmune encephalomyelitis. J Immunol. 2011;186:6955–6964. doi: 10.4049/jimmunol.1004043.
- 45.Rouse M, Nagarkatti M, Nagarkatti PS. The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis. Immunobiology. 2013;218:674–682. doi: 10.1016/j.imbio.2012.08.269.
- 46.Bam M, et al. Evidence for Epigenetic Regulation of Pro-Inflammatory Cytokines, Interleukin-12 and Interferon Gamma, in Peripheral Blood Mononuclear Cells from PTSD Patients. J Neuroimmune Pharmacol. 2016;11:168–181. doi: 10.1007/s11481-015-9643-8.
- 47.Krzywinski M, et al. Circos: an information aesthetic for comparative genomics. Genome Res. 2009;19:1639–1645. doi: 10.1101/gr.092759.109.
- 48.Heinz S, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38:576–589. doi: 10.1016/j.molcel.2010.05.004.